CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Glucose-Lowering Agents and COVID-19
Ah Reum Khang
J Korean Diabetes. 2022;23(1):1-6.   Published online March 31, 2022
DOI: https://doi.org/10.4093/jkd.2022.23.1.1

Excel Download

Glucose-Lowering Agents and COVID-19
The Journal of Korean Diabetes. 2022;23(1):1-6   Crossref logo
Link1 Link2 Link3

Mechanisms and Potential Roles of Glucose-Lowering Agents in COVID-19: A Review
Annals of Pharmacotherapy. 2021;55(11):1386-1396   Crossref logo
Link1 Link2 Link3

Use of Available Glucose-Lowering Agents in Patients with Different Levels of Renal Impairment
Endocrine Practice. 2013;19:14-18   Crossref logo
Link1 Link2 Link3

4396602 Blood glucose level lowering agents
Biotechnology Advances. 1983;1(2):340   Crossref logo
Link1 Link2

From glucose lowering to treatment of cardiovascular disease: the repositioning of glucose-lowering agents
European Heart Journal - Cardiovascular Pharmacotherapy. 2020;7(2):83-85   Crossref logo
Link1 Link2

Glucose-Lowering Agents in the Management of Nonalcoholic Fatty Liver Disease
The Journal of Korean Diabetes. 2018;19(2):88   Crossref logo
Link1 Link2 Link3

Glucose-lowering treatments and COVID-19 mortality in T2DM
Nature Reviews Endocrinology. 2021;17(7):387-388   Crossref logo
Link1 Link2 Link3

Diabetes, bone and glucose-lowering agents: basic biology
Diabetologia. 2017;60(7):1163-1169   Crossref logo
Link1 Link2 Link3

Diabetes, bone and glucose-lowering agents: clinical outcomes
Diabetologia. 2017;60(7):1170-1179   Crossref logo
Link1 Link2 Link3

Can glucose-lowering drugs affect the prognosis of COVID-19 in patients with type 2 diabetes?
The Lancet Diabetes & Endocrinology. 2021;9(5):251-252   Crossref logo
Link1 Link2